Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists

Leonid N. Maslov, Igor Khaliulin, Peter R. Oeltgen, Natalia V. Naryzhnaya, Jian Ming Pei, Stephen A. Brown, Yury B. Lishmanov, James M. Downey

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

It has now been demonstrated that the μ, δ1, δ2, and κ1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias.

Original languageEnglish
Pages (from-to)871-923
Number of pages53
JournalMedicinal Research Reviews
Volume36
Issue number5
DOIs
Publication statusPublished - 1 Sep 2016

Fingerprint

Anti-Arrhythmia Agents
Opioid Receptors
Opioid Analgesics
Reperfusion
Ischemia
Cardiac Myocytes
Heart Injuries
Cardiac Arrhythmias
Necrosis
Apoptosis
Pharmaceutical Preparations

Keywords

  • cardioprotection
  • heart
  • ischemia/reperfusion injury
  • opioids
  • signal transduction

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Maslov, L. N., Khaliulin, I., Oeltgen, P. R., Naryzhnaya, N. V., Pei, J. M., Brown, S. A., ... Downey, J. M. (2016). Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists. Medicinal Research Reviews, 36(5), 871-923. https://doi.org/10.1002/med.21395

Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists. / Maslov, Leonid N.; Khaliulin, Igor; Oeltgen, Peter R.; Naryzhnaya, Natalia V.; Pei, Jian Ming; Brown, Stephen A.; Lishmanov, Yury B.; Downey, James M.

In: Medicinal Research Reviews, Vol. 36, No. 5, 01.09.2016, p. 871-923.

Research output: Contribution to journalReview article

Maslov, LN, Khaliulin, I, Oeltgen, PR, Naryzhnaya, NV, Pei, JM, Brown, SA, Lishmanov, YB & Downey, JM 2016, 'Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists', Medicinal Research Reviews, vol. 36, no. 5, pp. 871-923. https://doi.org/10.1002/med.21395
Maslov, Leonid N. ; Khaliulin, Igor ; Oeltgen, Peter R. ; Naryzhnaya, Natalia V. ; Pei, Jian Ming ; Brown, Stephen A. ; Lishmanov, Yury B. ; Downey, James M. / Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists. In: Medicinal Research Reviews. 2016 ; Vol. 36, No. 5. pp. 871-923.
@article{981cf975beb24369afc37a3e6a08077d,
title = "Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists",
abstract = "It has now been demonstrated that the μ, δ1, δ2, and κ1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias.",
keywords = "cardioprotection, heart, ischemia/reperfusion injury, opioids, signal transduction",
author = "Maslov, {Leonid N.} and Igor Khaliulin and Oeltgen, {Peter R.} and Naryzhnaya, {Natalia V.} and Pei, {Jian Ming} and Brown, {Stephen A.} and Lishmanov, {Yury B.} and Downey, {James M.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1002/med.21395",
language = "English",
volume = "36",
pages = "871--923",
journal = "Medicinal Research Reviews",
issn = "0198-6325",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists

AU - Maslov, Leonid N.

AU - Khaliulin, Igor

AU - Oeltgen, Peter R.

AU - Naryzhnaya, Natalia V.

AU - Pei, Jian Ming

AU - Brown, Stephen A.

AU - Lishmanov, Yury B.

AU - Downey, James M.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - It has now been demonstrated that the μ, δ1, δ2, and κ1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias.

AB - It has now been demonstrated that the μ, δ1, δ2, and κ1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias.

KW - cardioprotection

KW - heart

KW - ischemia/reperfusion injury

KW - opioids

KW - signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84981489371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981489371&partnerID=8YFLogxK

U2 - 10.1002/med.21395

DO - 10.1002/med.21395

M3 - Review article

VL - 36

SP - 871

EP - 923

JO - Medicinal Research Reviews

JF - Medicinal Research Reviews

SN - 0198-6325

IS - 5

ER -